Lars Erik Bryld
Klinisk lektor
1 - 2 ud af 2Pr. side: 10
- 2017
- Udgivet
Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis: nationwide results from the DERMBIO registry
Egeberg, A., Iversen, L., Gniadecki, R., Hvid, L., Dam, T. N., Bryld, Lars Erik & Skov, Lone, 2017, I: Journal of the European Academy of Dermatology and Venereology. 31, 7, s. 1183-1187Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
- Udgivet
Treatment history of patients receiving biologic therapy for psoriasis
Loft, N., Skov, Lone, Bryld, Lars Erik, Gislason, Gunnar Hilmar & Egeberg, A., 2017, I: Journal of the European Academy of Dermatology and Venereology. 31, 8, s. e362-e363Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning
ID: 32369880
Flest downloads
-
74
downloads
Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
16
downloads
Response to biologics during the first six months of therapy in biologic-naïve patients with psoriasis predicts risk of disease flares: A danish nationwide study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet